AQR CAPITAL MANAGEMENT LLC

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1167557 Greenwich, CT

Position in CTMX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$157,551

-$559,552 QoQ

Shares Held

42,014

-89.3% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#107

of 178 holders

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,647,082,398 across 216 Biotechnology names. CTMX ranks #208 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,126,080	$702,155,918
2	INCY	Incyte Corp	5,320,901	$603,177,333
3	EXEL	Exelixis, Inc.	11,023,943	$599,812,735
4	JAZZ	Jazz Pharmaceuticals plc	1,522,568	$366,893,205
5	BMRN	Biomarin Pharmaceutical Inc	5,699,541	$326,127,732
6	VRTX	Vertex Pharmaceuticals Inc / Ma	616,170	$306,070,117
7	RVMD	Revolution Medicines, Inc.	1,295,450	$242,611,869
8	RPRX	Royalty Pharma plc	4,305,412	$241,404,446

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$157,551	42,014	-89.3%	Shares	Defined	2026-08-14
2022-06-30	$717,103	391,860	+2141.0%	Shares	Defined	2022-08-15
2021-09-30	$89,003	17,486	-87.0%	Shares	Defined	2021-11-15
2021-06-30	$850,024	134,285	+32.9%	Shares	Defined	2021-08-16
2021-03-31	$780,791	101,008	-18.5%	Shares	Defined	2021-05-17
2020-12-31	$811,734	123,929	+1.6%	Shares	Defined	2021-02-16
2020-09-30	$811,246	121,992	-35.9%	Shares	Defined	2020-11-16
2020-06-30	$1,585,407	190,325	+35.6%	Shares	Defined	2020-08-17
2020-03-31	$1,076,400	140,339	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.